Senti Biosciences
SNTI
SNTI
45 hedge funds and large institutions have $180M invested in Senti Biosciences in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.68M | |
| 2 | +$5.4M | |
| 3 | +$4.47M | |
| 4 |
Millennium Management
New York
|
+$4.22M |
| 5 |
IPCP
Iron Park Capital Partners
New York
|
+$2.23M |
Top Sellers
| 1 | -$7.63M | |
| 2 | -$5.08M | |
| 3 | -$2.96M | |
| 4 |
CAC
Cowen and Company
New York
|
-$1.81M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$1.73M |